Florian Brand
Founder @ Prox Ventures
Kreuzberg, Germany
Florian Brand is a Series A investor at Prox Ventures in Kreuzberg focused on Health Care and Biotechnology. Florian Brand is based out of Berlin, Berlin and is the Founder of Prox Ventures. Florian previously worked at AtaiBeckley as a CEO and Co-Founder. Florian Brand attended ESCP Business School. Florian Brand has received the 40 under 40 award.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Florian Brand invests in
Stages Florian Brand invests in
Countries Florian Brand invests in
Investment Focus
Industry
- Health Care 3 (75%)
- Biotechnology 2 (50%)
- Wellness 1 (25%)
- Life Science 1 (25%)
- Mental Health 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
- Post-IPO Debt 1 (25%)
- Post-IPO Equity 1 (25%)
Country
- Canada 1 (25%)
- Germany 1 (25%)
- United Kingdom 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kranus Health
|
Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently. | $6.5M / Series A / Jun 20, 2022 | |
IntelGenX
|
IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP,and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients. | $12.3M / Post-IPO Equity / Mar 15, 2021 | |
|
IntelGenX
|
IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP,and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients. | $2M / Post-IPO Debt / Mar 15, 2021 | |
COMPASS Pathways
|
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression.Compass Pathways conducts clinical trials and research toassess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression. | $80M / Series B / Apr 27, 2020 |
Co-Investors
About Prox Ventures
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Prox Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Florian Brand
Founder
|
|||
|
Li Qian
Project leader
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Florian Brand invest in?
Florian Brand invests primarily in Health Care, Biotechnology and Wellness startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Florian Brand last invest?
The most recent investment recorded for Florian Brand closed in Jun 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
